Niki Fang


San Francisco

Niki Fang is a partner in Orrick’s Capital Markets practice.

Niki concentrates her corporate practice on representing issuers and underwriters in public offerings and capital markets transactions.  Niki also regularly counsels public and late-stage private companies on securities law compliance, disclosure matters, SEC reporting obligations, corporate governance and stock exchange listing obligations. In addition, Niki’s practice includes venture capital financings and advising start-up companies on general corporate matters. She represents a wide range of technology and life sciences companies, from privately held start-ups to publicly traded corporations.

Prior to joining Orrick, Niki was at Fenwick & West LLP and Davis Polk & Wardwell LLP.

  • A representative listing of Niki’s recent transactions include:

    • BioAtla on its $65 million underwritten offering and the establishment of its up to $100 million at the market offering.
    • Ipsen on its acquisition of Albireo Pharma Inc, and related tender offer
    • DURECT Corporation on its $10 million registered direct offering
    • Getaround, a connected carsharing marketplace, on its business combination with InterPrivate II Acquisition Corp.
    • Weave Communications on its $120 million initial public offering
    • Underwriters led by Morgan Stanley, J.P. Morgan, and BofA Securities on the $1 billion initial public offering of Freshworks
    • BioAlta on its $75 million PIPE offering
    • Asana, Inc. on its direct listing on the New York Stock Exchange and related $450 million senior mandatory convertible promissory note financing
    • Clover Health Investments, Corp., a next-generation Medicare Advantage insurer, on its business combination with Social Capital Hedosophia Holdings Corp. III.
    • Sonos on its $95.8 million initial public offering
    • Redfin on its $258.3 million concurrent public offerings of common stock and convertible notes
    • Cloudera on its $258.8 million initial public offering and its $254 million follow-on offering
    • Chegg on its $155.3 million follow-on offering
    • GoPro on its $175 million convertible senior notes offering
    • Workday in various transactions including its $732.5 million IPO, its $534 million follow-on offering and its $1 billion convertible senior notes offering
    • Castlight Health on its $204 million initial public offering
    • Gridsum Holdings on its $100 million initial public offering
    • Aeglea Biotherapeutics on its $54.8 million initial public offering
    • BioPharmx on its $10 million public offering and simultaneous uplisting to NYSE American and its $11 million follow-on offering
    • Adesto Technologies on its $17.5 million and $40.2 million follow-on offerings
    • Underwriters led by Morgan Stanley and Goldman Sachs on the $100 million initial public offering of MobileIron
    • Underwriters led by Morgan Stanley, J.P. Morgan and BofA Merrill Lynch on the $86 million initial public offering of Barracuda Networks
    • Symantec on its $500 million strategic investment by Silver Lake
    • Sojern on its $120 million financing round led by TCV
    • Quizlet on its $12 million Series A financing
    • MyFitnessPal on its $18 million Series A financing
    • Cloudera on its $5.2 billion merger with Hortonworks
    • Silver Spring Networks on its $830 million acquisition by Itron
    • Castlight Health on its strategic acquisition of Jiff, Inc.

    Speaking Engagements

    • TechGC IPO Forum: Roundtable session with Taylor Browning, General Counsel of BloomReach on "Beyond The Checklist: Mastering the Intersection of Company Culture and the IPO Process." (September 2021)
    • TechGC SPAC & Direct Listing Forum: Panel discussion with Eleanor Lacey and Rowan Reynolds from Asana on "Buttoning Up for a Direct Listing: Considerations, Unique Characteristics, and Reflections." (February 2021)
    • Where from Here? A discussion of SPAC transactions, featuring Clover Health GC Gia Lee (Orrick webinar, January 2021)